CI
KZR

Cowen Inc’s Kezar Life Sciences KZR Stock Holding History

Cowen Inc’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.65M Sell
34,305
-14,896
-30% -$2.32M 0.19% 95
2019
Q1 		$8.73M Sell
49,201
-34,119
-41% -$6.72M 0.94% 17
2018
Q4 		$19.7M Sell
83,320
-27,289
-25% -$6.67M 2.18% 9
2018
Q3 		$23.7M Buy
110,609
+5,367
+5% +$937K 2.16% 8
2018
Q2 		$18.2K Buy
+105,242
New +$18.4M 0.77% 21

Other funds holding KZR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cowen Inc's KZR Position: Q2 2019 in Review

Cowen Inc reduced its Kezar Life Sciences (KZR) stake by 30% in Q2 2019, selling an estimated $2.32M and leaving 34,305 shares worth $2.65M. The position accounts for 0.19% of the portfolio, ranked #95.

Cowen Inc first reported a position in KZR in Q2 2018 and has held it in 5 quarters since. The position peaked at $23.7M in Q3 2018. 54 funds tracked by Wall St. Rank hold KZR as of Q2 2019.

  • Cowen Inc held 34,305 shares of Kezar Life Sciences worth $2.65M as of Q2 2019.
  • Cowen Inc sold 14,896 Kezar Life Sciences shares in Q2 2019, an estimated $2.32M.
  • Kezar Life Sciences made up 0.19% of Cowen Inc's portfolio in Q2 2019, its #95 holding.
  • Cowen Inc first reported a position in Kezar Life Sciences in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's Kezar Life Sciences position peaked at $23.7M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.